These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 1407245)

  • 21. Islet amyloid polypeptide/amylin contents in pancreata increase in genetically obese and diabetic mice.
    Tokuyama Y; Kanatsuka A; Yamaguchi T; Ohsawa H; Makino H; Nishimura M; Yoshida S
    Horm Metab Res; 1993 Jun; 25(6):289-91. PubMed ID: 8344641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amylin: history and overview.
    Ludvik B; Kautzky-Willer A; Prager R; Thomaseth K; Pacini G
    Diabet Med; 1997 Jun; 14 Suppl 2():S9-13. PubMed ID: 9212323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Role of amylin in glucose homeostasis and its perspective use in diabetes management].
    Otto-Buczkowska E; Mazur-Dworzecka U; Dworzecki T
    Przegl Lek; 2008; 65(3):135-9. PubMed ID: 18624122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Amylin/IAPP (islet amyloid polypeptide)--physiology and clinical significance].
    Ludvik B
    Wien Klin Wochenschr; 1997 Jun; 109(11):379-83. PubMed ID: 9281227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amylin found in amyloid deposits in human type 2 diabetes mellitus may be a hormone that regulates glycogen metabolism in skeletal muscle.
    Cooper GJ; Leighton B; Dimitriadis GD; Parry-Billings M; Kowalchuk JM; Howland K; Rothbard JB; Willis AC; Reid KB
    Proc Natl Acad Sci U S A; 1988 Oct; 85(20):7763-6. PubMed ID: 3051005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Banting lecture 1990. Beta-cells in type II diabetes mellitus.
    Porte D
    Diabetes; 1991 Feb; 40(2):166-80. PubMed ID: 1991568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microwave assisted SPPS of amylin and its toxicity of the pure product to RIN-5F cells.
    Muthusamy K; Albericio F; Arvidsson PI; Govender P; Kruger HG; Maguire GE; Govender T
    Biopolymers; 2010; 94(3):323-30. PubMed ID: 20069542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypocalcemic actions of amylin amide in humans.
    Wimalawansa SJ; Gunasekera RD; Datta HK
    J Bone Miner Res; 1992 Sep; 7(9):1113-6. PubMed ID: 1414504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amylin, amyloid and age-related disease.
    Cooper GJ; Tse CA
    Drugs Aging; 1996 Sep; 9(3):202-12. PubMed ID: 8877314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Amylin, islet amyloid and diabetes mellitus type II].
    Fehmann HC; Göke B
    Dtsch Med Wochenschr; 1990 Nov; 115(46):1769-72. PubMed ID: 2226190
    [No Abstract]   [Full Text] [Related]  

  • 31. Islet amyloid polypeptide: does it play a pathophysiological role in the development of diabetes?
    Bennet WM; Smith DM; Bloom SR
    Diabet Med; 1994 Nov; 11(9):825-9. PubMed ID: 7705017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Basal and stimulated plasma levels of pancreatic amylin indicate its co-secretion with insulin in humans.
    Hartter E; Svoboda T; Ludvik B; Schuller M; Lell B; Kuenburg E; Brunnbauer M; Woloszczuk W; Prager R
    Diabetologia; 1991 Jan; 34(1):52-4. PubMed ID: 2055340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spontaneous diabetes in hemizygous human amylin transgenic mice that developed neither islet amyloid nor peripheral insulin resistance.
    Wong WP; Scott DW; Chuang CL; Zhang S; Liu H; Ferreira A; Saafi EL; Choong YS; Cooper GJ
    Diabetes; 2008 Oct; 57(10):2737-44. PubMed ID: 18633116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design and study of peptide-based inhibitors of amylin cytotoxicity.
    Muthusamy K; Arvidsson PI; Govender P; Kruger HG; Maguire GE; Govender T
    Bioorg Med Chem Lett; 2010 Feb; 20(4):1360-2. PubMed ID: 20093026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Mutation of amylin (IAPP) gene].
    Sakagashira S; Sanke T
    Nihon Rinsho; 2002 Jul; 60 Suppl 7():653-8. PubMed ID: 12238114
    [No Abstract]   [Full Text] [Related]  

  • 36. In vivo glucose-stimulated amylin secretion is increased in nondiabetic patients with pancreatic cancer.
    Mäkimattila S; Hietaniemi K; Kiviluoto T; Timonen T; Yki-Järvinen H
    Metabolism; 2001 Sep; 50(9):1036-42. PubMed ID: 11555835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amylin.
    Edwards BJ; Morley JE
    Life Sci; 1992; 51(25):1899-912. PubMed ID: 1453875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amylin modulates beta-cell glucose sensing via effects on stimulus-secretion coupling.
    Wagoner PK; Chen C; Worley JF; Dukes ID; Oxford GS
    Proc Natl Acad Sci U S A; 1993 Oct; 90(19):9145-9. PubMed ID: 8415669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Link between Type 2 Diabetes and Neurodegeneration: Roles for Amyloid-β, Amylin, and Tau Proteins.
    Bharadwaj P; Wijesekara N; Liyanapathirana M; Newsholme P; Ittner L; Fraser P; Verdile G
    J Alzheimers Dis; 2017; 59(2):421-432. PubMed ID: 28269785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of amylin and related peptides in osteoporosis.
    Bronský J; Průsa R; Nevoral J
    Clin Chim Acta; 2006 Nov; 373(1-2):9-16. PubMed ID: 16797521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.